The invention relates to design of copolymers having {HEAD ~ particular amino acids} in specific molar ratios, synthesized into polypeptides of predetermined length and capable of suppression of symptoms and frequency of {TAIL ~ recurrent episodes} of an autoimmune disease 
The invention relates to design of copolymers having { HEAD ~ particular amino acids } in specific molar ratios , synthesized into polypeptides of predetermined length and capable of suppression of symptoms and frequency of { TAIL ~ recurrent episodes } of an autoimmune disease
OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH